# A mitochondrial percentage needs its tissue beside it

Draft • Research checked 4 October 2026 • AI-assisted DomDNA editorial content. No independent clinical review or publication is claimed. General education, not individual medical advice.

A mitochondrial result may contain a percentage that looks like a direct measure of disease severity. It can instead describe heteroplasmy: a mixture of mitochondrial DNA variants in the material examined. Understanding that distinction prevents a technical proportion from becoming a personal prognosis.

Mitochondria have their own DNA, alongside the DNA in the cell nucleus. Mitochondrial conditions can involve either source. A mitochondrial test therefore needs a clear purpose and method, not just a percentage.

## Many copies, possible mixtures

The [MedlinePlus mitochondrial-DNA explanation](https://www.medlineplus.gov/genetics/chromosome/mitochondrial-dna/) provides the basic distinction between mitochondrial and nuclear genetic material. A mitochondrial result is not simply a standard two-copy autosomal genotype with a different gene name.

The [NHS mitochondrial-inheritance resource](https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/mitochondrial-conditions/) discusses heteroplasmy and the complexity of mitochondrial inheritance. The concept helps explain why a simple family-tree calculation may not answer an individual question.

Here is a hypothetical teaching example. In a laboratory sample, some mitochondrial DNA copies carry one sequence and others carry another. A reported proportion describes that mixture under the laboratory's method. It does not say that the same proportion occurs in every organ or that a matching proportion of the person's health has been lost.

Numbers make this distinction particularly important. A result that says thirty per cent does not mean thirty per cent of the body is affected, thirty per cent of mitochondria are non-functional or a thirty per cent chance of developing a condition. Those are different claims.

## The tissue can change the interpretation

The [NHS mitochondrial-DNA testing explanation](https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/mitochondrial-dna-testing/) notes that heteroplasmic variants can occur at different levels across tissues. A variant absent from a blood sample may be detectable elsewhere in a relevant investigation.

That does not mean a reader should arrange a muscle biopsy or keep buying tests until a variant appears. Specimen selection is a clinical decision with practical and safety consequences. The source concerns investigating suspected mitochondrial conditions, not screening everyone who feels tired.

A hypothetical comparison illustrates why tissue labels matter. One report uses blood and another uses a different specimen. Even if both print the same variant name, you cannot treat their percentages as interchangeable measurements of a whole-body quantity.

The comparison also needs the method and collection context. A report's detection limit should remain part of its interpretation. “Not detected” should not be rewritten as “no mitochondrial condition is possible”.

## Keep inheritance and symptoms separate

Mitochondrial inheritance is often introduced through the maternal line, but that alone does not predict a particular person's symptoms or a child's outcome. Conditions involving nuclear genes may follow other inheritance patterns. Heteroplasmy introduces additional complexity for mitochondrial-DNA variants.

For family questions, retain the actual laboratory report and the clinical interpretation. A generic chart from a search result cannot supply the information needed for reproductive counselling.

Likewise, a symptom such as low energy does not identify mitochondrial disease. The sources explain a category of genetic testing; they do not support matching an everyday experience to a mitochondrial diagnosis or a supplement plan.

## A better way to summarise the report

A useful personal note can contain four items: the variant as written, the specimen, the reported proportion with its label, and the laboratory's conclusion. This is an editorial record-keeping suggestion, not a validated diagnostic tool.

If you compare reports, add whether they used the same method and tissue. Leave missing information visibly missing. Do not average percentages from different specimens to create a supposedly more representative number.

Ask what the reported proportion helps the clinical team understand and what it cannot establish. That invites an explanation of the actual result rather than a general discussion of whether a number is high or low.

## What you can do with this

Your practical next step is to find the specimen field before interpreting a mitochondrial percentage. If the result has clinical significance or raises family questions, bring the complete report to the relevant genetics or mitochondrial service.

The percentage has a place in the assessment. Keeping its tissue and method beside it prevents it from being promoted into a prognosis it was never designed to provide.

For general lifestyle learning, [DomDNA’s educational quiz](https://domdna.com/quiz) does not interpret mitochondrial results or diagnose causes of fatigue.